Four things to know:
1. The company’s net sales of $233.4 million was an 11.5 percent decrease from the same time last year.
2. Third-party spine and dental sales decreased year over year as well. Spine sales were $115.2 million, a 19.6 percent dip, while dental sales were $118.2 million, a 1.8 percent decrease.
3. ZimVie saw an $8.7 million net loss in the second quarter. It was primarily because of a decline in spine business, according to the report.
4. The company’s full-year guidance was adjusted, and the projected revenue for 2022 fell from $1 billion to an estimated $915 million to $930 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
